Dubuque Bank & Trust’s Novo Nordisk NVO Stock Holding History

Dubuque Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-750	Closed	-$20K	–	468
2019 Q1	$20K	Hold	750	–	–	﹤0.01%	381
2018 Q4	$17K	Hold	750	–	–	﹤0.01%	379
2018 Q3	$18K	Hold	750	–	–	﹤0.01%	372
2018 Q2	$17K	Hold	750	–	–	﹤0.01%	412
2018 Q1	$18K	Hold	750	–	–	﹤0.01%	441
2017 Q4	$20K	Hold	750	–	–	﹤0.01%	436
2017 Q3	$18K	Hold	750	–	–	﹤0.01%	422
2017 Q2	$16K	Sell	750 -300	-29%	-$6.05K	﹤0.01%	421
2017 Q1	$18K	Hold	1,050	–	–	﹤0.01%	433
2016 Q4	$19K	Hold	1,050	–	–	﹤0.01%	345
2016 Q3	$22K	Hold	1,050	–	–	﹤0.01%	311
2016 Q2	$28K	Hold	1,050	–	–	0.01%	308
2016 Q1	$28K	Buy	1,050 +750	+250%	+$20.1K	0.01%	302
2015 Q4	$9K	Buy	+300	New	+$8.3K	﹤0.01%	532
2014 Q1	–	Sell	-500	Closed	-$9K	–	456
2013 Q4	$9K	Buy	+500	New	+$8.71K	﹤0.01%	365

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Dubuque Bank & Trust's NVO Position: Q2 2019 in Review

Dubuque Bank & Trust sold out of Novo Nordisk (NVO) in Q2 2019, closing a stake of 750 shares — an estimated $20K sold.

Dubuque Bank & Trust first reported a position in NVO in Q4 2013 and held it in 15 quarters. The position peaked at $28K in Q2 2016. 559 funds tracked by Wall St. Rank hold NVO as of Q2 2019.

Dubuque Bank & Trust reported no remaining Novo Nordisk position as of Q2 2019 after selling out during the quarter.
Dubuque Bank & Trust sold 750 Novo Nordisk shares in Q2 2019, an estimated $20K.
Dubuque Bank & Trust first reported a position in Novo Nordisk in Q4 2013 and held it in 15 quarters.
Dubuque Bank & Trust's Novo Nordisk position peaked at $28K in Q2 2016.
559 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2019.

Based on Dubuque Bank & Trust's 13F filing for Q2 2019, filed 10 Jul 2019.